The Cancer Vaccine Center is Developing
Safe, Effective Vaccines for Patients With Cancer

  • Image
  • Image
  • Image

Welcome to the Cancer Vaccine Center (CVC). We are developing safe and effective vaccines for patients with cancer. The CVC maintains an integrated program of scientific discovery, preclinical vaccine development and clinical investigation. As part of Dana-Farber Cancer Institute, the CVC is affiliated with Harvard Medical School and Dana-Farber/Harvard Cancer Center.


  • Image

CVC Feature

FDA approves new drug for advanced melanoma - The U.S. Food and Drug Administration today approved the use of ipilimumab for the treatment of previously treated metastatic melanoma. It is the first drug approved for metastatic, or advanced, melanoma in more than a decade.

More details

Leadership & Innovation

The CVC in conjunction with Dana-Farber Cancer Institute combines comprehensive facilities and capabilities to streamline the development of cancer vaccines.

Latest CVC News

11.02.09 Study Reveals "Missing Link" in Immune Response to Disease. Investigators Sun Taek Kim, Ellis L. Reinherz et al. describe how T cell receptors can ...

READ MORE | VIEW MORE NEWS